Literature DB >> 11119494

Time between inoculations and karyotype forms of Pneumocystis carinii f. sp. Carinii influence outcome of experimental coinfections in rats.

M T Cushion1, S Orr, S P Keely, J R Stringer.   

Abstract

The prevalence of Pneumocystis carinii pneumonia (PCP) in humans caused by more than a single genotype has been reported to range from 10 to 67%, depending on the method used for detection (3, 19). Most coinfections were associated with primary rather than recurrent disease. To better understand the factors influencing the development of coinfections, the time periods between inoculations and the genotype of the infecting organisms were evaluated in the chronically immunosuppressed-inoculated rat model of PCP. P. carinii f. sp. carinii infecting rats differentiated by karyotypic profiles exhibit the same low level of genetic divergence manifested by organisms infecting humans. P. carinii f. sp. carinii karyotype forms 1, 2, and 6 were inoculated into immunosuppressed rats, individually and in dual combinations, spaced 0, 10, and 20 days apart. Infections comprised of both organism forms resulted from admixtures inoculated at the same time. In contrast, coinfections did not develop in most rats, where a 10- or 20-day gap was inserted between inoculations; only the first organism form inoculated was detected by pulsed-field gel electrophoresis in the resultant infection. Organism burdens were reduced with combinations of forms 1 and 2 spaced 20 days apart but not in rats inoculated with forms 1 and 6. A role for the host response in the elimination of the second population and in reduction of the organism burden was suggested by the lack of direct killing of forms 1 and 2 in an in vitro ATP assay, by reduction of the burden by autoclaved organisms, and by the specific reactions of forms 1 and 2 but not forms 1 and 6. These studies showed that the time between inoculations was critical in establishing coinfections and P. carinii f. sp. carinii karyotype profiles were associated with differences in biological responses. This model provides a useful method for the study of P. carinii coinfections and their transmission in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119494      PMCID: PMC97860          DOI: 10.1128/IAI.69.1.97-107.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Genetic heterogeneity of rat-derived Pneumocystis.

Authors:  M T Cushion
Journal:  FEMS Immunol Med Microbiol       Date:  1998-09

Review 2.  Pneumocystis carinii: what is it, exactly?

Authors:  J R Stringer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Vegetative incompatibility in filamentous fungi: het genes begin to talk.

Authors:  J Bégueret; B Turcq; C Clavé
Journal:  Trends Genet       Date:  1994-12       Impact factor: 11.639

4.  Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia.

Authors:  P D Walzer; M LaBine; T J Redington; M T Cushion
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

5.  Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes.

Authors:  C H Lee; J Helweg-Larsen; X Tang; S Jin; B Li; M S Bartlett; J J Lu; B Lundgren; J D Lundgren; M Olsson; S B Lucas; P Roux; A Cargnel; C Atzori; O Matos; J W Smith
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).

Authors:  M S Bartlett; J A Fishman; M M Durkin; S F Queener; J W Smith
Journal:  Exp Parasitol       Date:  1990-01       Impact factor: 2.011

7.  Molecular characterization of a novel repetitive element from Pneumocystis carinii from rats.

Authors:  J Zhang; M T Cushion; J R Stringer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii.

Authors:  F Gigliotti
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

9.  Antigenic differences associated with genetically distinct Pneumocystis carinii from rats.

Authors:  J Vasquez; A G Smulian; M J Linke; M T Cushion
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Pneumocystis carinii is not universally transmissible between mammalian species.

Authors:  F Gigliotti; A G Harmsen; C G Haidaris; P J Haidaris
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  8 in total

1.  Gene arrays at Pneumocystis carinii telomeres.

Authors:  Scott P Keely; Hubert Renauld; Ann E Wakefield; Melanie T Cushion; A George Smulian; Nigel Fosker; Audrey Fraser; David Harris; Lee Murphy; Claire Price; Michael A Quail; Kathy Seeger; Sarah Sharp; Carolyn J Tindal; Tim Warren; Eduard Zuiderwijk; Barclay G Barrell; James R Stringer; Neil Hall
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

2.  Rapid PCR-single-strand conformation polymorphism method to differentiate and estimate relative abundance of Pneumocystis carinii special forms infecting rats.

Authors:  A Nahimana; M T Cushion; D S Blanc; P M Hauser
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds.

Authors:  Melanie T Cushion; Peter D Walzer; Margaret S Collins; Sandra Rebholz; Jean Jacques Vanden Eynde; Annie Mayence; Tien L Huang
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription.

Authors:  Scott P Keely; Michael J Linke; Melanie T Cushion; James R Stringer
Journal:  Fungal Genet Biol       Date:  2007-01-10       Impact factor: 3.495

Review 5.  Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.

Authors:  Adélaïde Chesnay; Christophe Paget; Nathalie Heuzé-Vourc'h; Thomas Baranek; Guillaume Desoubeaux
Journal:  J Fungi (Basel)       Date:  2022-01-27

6.  Biofilm formation by Pneumocystis spp.

Authors:  Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal:  Eukaryot Cell       Date:  2008-09-26

7.  Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast.

Authors:  Theodore J Kottom; Julia R Köhler; Charles F Thomas; Gerald R Fink; Andrew H Limper
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Pneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptors.

Authors:  Jianmin Zhang; Jinping Zhu; Amy Imrich; Melanie Cushion; T Bernard Kinane; Henry Koziel
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.